Matthew Outten

Corporate Officer/Principal presso BRIDGEBIO PHARMA, INC.

51 anni

Health Technology

Consumer Services

Profilo

Matthew Outten is currently Chief Commercial Officer at QED Therapeutics, Inc. and Chief Commercial Officer at BridgeBio Pharma, Inc. Formerly, Mr. Outten was Vice President-Marketing & Marketing Access at Pharmacyclics LLC from 2013 to 2018.
Education includes an undergraduate degree from Hamilton College (New York) and an MBA from the University of Delaware.

Posizioni attive di Matthew Outten

Società	Posizione	Inizio
BRIDGEBIO PHARMA, INC.	Corporate Officer/Principal	01/02/2019
QED Therapeutics, Inc. QED Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals	Corporate Officer/Principal	-

Tutte le posizioni attive di Matthew Outten

Precedenti posizioni note di Matthew Outten

Società	Posizione	Fine
PHARMACYCLICS, INC.	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Matthew Outten

Formazione di Matthew Outten

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Vedi nel dettaglio l'esperienza di Matthew Outten

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	5
Pharmacyclics LLC Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis	Health Technology
Hamilton College (New York) Hamilton College (New York) Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Delaware University of Delaware Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
QED Therapeutics, Inc. QED Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals	Health Technology
BridgeBio Pharma, Inc. BridgeBio Pharma, Inc. BiotechnologyHealth Technology Develops medicines for genetic diseases to patients	Health Technology